Literature DB >> 15480602

"Dark" (compacted) neurons may not die through the necrotic pathway.

Ferenc Gallyas1, Attila Csordás, Attila Schwarcz, Mária Mázló.   

Abstract

"Dark" neurons were produced in the cortex of the rat brain by hypoglycemic convulsions. In the somatodendritic domain of each affected neuron, the ultrastructural elements, except for disturbed mitochondria, were remarkably preserved during the acute stage, but the distances between them were reduced dramatically (ultrastructural compaction). Following a 1-min convulsion period, only a few neurons were involved and their environment appeared undamaged. In contrast, 1-h convulsions affected many neurons and caused swelling of astrocytic processes and neuronal dendrites (excitotoxic neuropil). A proportion of "dark" neurons recovered the normal structure in 2 days. The non-recovering "dark" neurons were removed from the brain cortex through two entirely different pathways. In the case of 1-h convulsions, their organelles swelled, then disintegrated and finally dispersed into the neuropil through large gaps in the plasma membrane (necrotic-like removal). Following a 1-min convulsion period, the non-recovering "dark" neurons fell apart into membrane-bound fragments that retained the compacted interior even after being engulfed by astrocytes or microglial cells (apoptotic-like removal). Consequently, in contrast to what is generally accepted, the "dark" neurons produced by 1-min hypoglycemic convulsions do not die as a consequence of necrosis. As regards the case of 1-h convulsions, it is assumed that a necrotic-like removal process is imposed, by an excitotoxic environment, on "dark" neurons that previously died through a non-necrotic pathway. Apoptotic neurons were produced in the hippocampal dentate gyrus by intraventricularly administered colchicine. After the biochemical processes had been completed and the chromatin condensation in the nucleus had reached an advanced phase, the ultrastructural elements in the somatodendritic cytoplasm of the affected cells became compacted. If present in an apparently undamaged environment such apoptotic neurons were removed from the dentate gyrus through the apoptotic sequence of morphological changes, whereas those present in an impaired environment were removed through a necrotic-like sequence of morphological changes. This suggests that the removal pathway may depend on the environment and not on the death pathway, as also assumed in the case of the "dark" neurons produced by hypoglycemic convulsions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480602     DOI: 10.1007/s00221-004-2037-4

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  26 in total

1.  Gel-to-gel phase transition may occur in mammalian cells: Mechanism of formation of "dark" (compacted) neurons.

Authors:  Ferenc Gallyas; Orsolya Farkas; Mária Mázló
Journal:  Biol Cell       Date:  2004-05       Impact factor: 4.458

2.  Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells.

Authors:  S Tan; M Wood; P Maher
Journal:  J Neurochem       Date:  1998-07       Impact factor: 5.372

3.  Both apoptosis and necrosis occur following intrastriatal administration of excitotoxins.

Authors:  I Ferrer; F Martin; T Serrano; J Reiriz; E Pérez-Navarro; J Alberch; A Macaya; A M Planas
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Binge ethanol exposure in adult rats causes necrotic cell death.

Authors:  J A Obernier; T W Bouldin; F T Crews
Journal:  Alcohol Clin Exp Res       Date:  2002-04       Impact factor: 3.455

5.  Localization and expression of Jun-like immunoreactivity in apoptotic neurons induced by colchicine administration in vivo and in vitro depends on the antisera used.

Authors:  E Pozas; F Aguado; I Ferrer
Journal:  Acta Neuropathol       Date:  1999-08       Impact factor: 17.088

6.  Recovery versus death of "dark" (compacted) neurons in non-impaired parenchymal environment: light and electron microscopic observations.

Authors:  A Csordás; M Mázló; F Gallyas
Journal:  Acta Neuropathol       Date:  2003-03-29       Impact factor: 17.088

7.  Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease.

Authors:  M Turmaine; A Raza; A Mahal; L Mangiarini; G P Bates; S W Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

8.  Intraventricular infusion of N-methyl-D-aspartate. 2. Acute neuronal consequences.

Authors:  W D Dietrich; M Halley; O Alonso; M Y Globus; R Busto
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  The temporal evolution of hypoglycemic brain damage. I. Light- and electron-microscopic findings in the rat cerebral cortex.

Authors:  R N Auer; H Kalimo; Y Olsson; B K Siesjö
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  An ultrastructural study of spontaneous cell death in a mouse mastocytoma with particular reference to dark cells.

Authors:  B V Harmon
Journal:  J Pathol       Date:  1987-12       Impact factor: 7.996

View more
  3 in total

Review 1.  New insights into mitochondrial structure during cell death.

Authors:  Guy Perkins; Ella Bossy-Wetzel; Mark H Ellisman
Journal:  Exp Neurol       Date:  2009-05-21       Impact factor: 5.330

2.  Spatiotemporal Progression of Microcalcification in the Hippocampal CA1 Region following Transient Forebrain Ischemia in Rats: An Ultrastructural Study.

Authors:  Tae-Ryong Riew; Yoo-Jin Shin; Hong Lim Kim; Jeong Min Cho; Ha-Jin Pak; Mun-Yong Lee
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

3.  Increased Expression of Osteopontin in the Degenerating Striatum of Rats Treated with Mitochondrial Toxin 3-Nitropropionic Acid: A Light and Electron Microscopy Study.

Authors:  Hong-Lim Kim; Mun-Yong Lee; Yoo-Jin Shin; Doo-Won Song; Jieun Park; Byung-Soo Chang; Jong-Hwan Lee
Journal:  Acta Histochem Cytochem       Date:  2015-10-21       Impact factor: 1.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.